TY - JOUR
T1 - Immunopathogenesis of Neuromyelitis Optica
AU - Levy, Michael
AU - Wildemann, Brigitte
AU - Jarius, Sven
AU - Orellano, Benjamine
AU - Sasidharan, Saranya
AU - Weber, Martin S.
AU - Stuve, Olaf
PY - 2014
Y1 - 2014
N2 - Neuromyelitis optica (NMO, Devic's syndrome) is a clinical syndrome characterized by optic neuritis and (mostly longitudinally extensive) myelitis. If untreated, NMO usually takes a relapsing course and often results in blindness and tetra- or paraparesis. The discovery of autoantibodies to aquaporin-4, the most abundant water channel in the CNS, in 70-80% of patients with NMO (termed NMO-IgG or AQP4-Ab) and subsequent investigations into the pathogenic impact of this new reactivity have led to the recognition of NMO as an autoimmune condition and as a disease entity in its own right, distinct from classic multiple sclerosis. Here, we comprehensively review the current knowledge on the role of NMO-IgG/AQP4-Ab, B cells, T cells, and the innate immune system in the pathogenesis of NMO.
AB - Neuromyelitis optica (NMO, Devic's syndrome) is a clinical syndrome characterized by optic neuritis and (mostly longitudinally extensive) myelitis. If untreated, NMO usually takes a relapsing course and often results in blindness and tetra- or paraparesis. The discovery of autoantibodies to aquaporin-4, the most abundant water channel in the CNS, in 70-80% of patients with NMO (termed NMO-IgG or AQP4-Ab) and subsequent investigations into the pathogenic impact of this new reactivity have led to the recognition of NMO as an autoimmune condition and as a disease entity in its own right, distinct from classic multiple sclerosis. Here, we comprehensively review the current knowledge on the role of NMO-IgG/AQP4-Ab, B cells, T cells, and the innate immune system in the pathogenesis of NMO.
KW - Aquaporin-4
KW - Immunopathogenesis
KW - Neuromyelitis optica
KW - NMO-IgG
UR - http://www.scopus.com/inward/record.url?scp=84891353177&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891353177&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-800100-4.00006-4
DO - 10.1016/B978-0-12-800100-4.00006-4
M3 - Article
C2 - 24388217
AN - SCOPUS:84891353177
SN - 0065-2276
VL - 121
SP - 213
EP - 242
JO - Advances in Immunology
JF - Advances in Immunology
ER -